Your browser doesn't support javascript.
loading
Positron Emission Tomography/Computed Tomography in Platinum-sensitive Recurrent Ovarian Cancer: A Single-center Italian Study.
Gadducci, Angiolo; Simonetti, Enrico; Manca, Gianpiero; Guidoccio, Federica; Fanucchi, Antonio; Cosio, Stefania; Volterrani, Duccio.
Afiliación
  • Gadducci A; Department of Clinical and Experimental Medicine, Division of Gynecology and Obstetrics, University of Pisa, Pisa, Italy a.gadducci@med.unipi.it.
  • Simonetti E; Department of Clinical and Experimental Medicine, Division of Gynecology and Obstetrics, University of Pisa, Pisa, Italy.
  • Manca G; Regional Center of Nuclear Medicine, Department of Translational Research, University of Pisa, Pisa, Italy.
  • Guidoccio F; Regional Center of Nuclear Medicine, Department of Translational Research, University of Pisa, Pisa, Italy.
  • Fanucchi A; Department of Clinical and Experimental Medicine, Division of Gynecology and Obstetrics, University of Pisa, Pisa, Italy.
  • Cosio S; Department of Clinical and Experimental Medicine, Division of Gynecology and Obstetrics, University of Pisa, Pisa, Italy.
  • Volterrani D; Regional Center of Nuclear Medicine, Department of Translational Research, University of Pisa, Pisa, Italy.
Anticancer Res ; 40(4): 2191-2197, 2020 Apr.
Article en En | MEDLINE | ID: mdl-32234914
ABSTRACT

AIM:

To assess the correlation between contrast-enhanced computed tomography (CE-CT) and positron-emission tomography (PET)/CT results and surgical and pathological findings in patients with recurrent platinum-sensitive ovarian cancer who underwent secondary cytoreduction. PATIENTS AND

METHODS:

18F-fluorodeoxyglucose (18F-FDG) PET/CT with/without CE-CT were performed before 56 cytoreductive surgeries in 49 patients with suspicious recurrent ovarian cancer.

RESULTS:

18F-FDG PET/CT showed higher sensitivity and diagnostic accuracy compared with CE-CT for both the whole series (100% versus 90.6%, respectively, and 97.8% versus 85.3%), and the 24 cases in which both examinations were performed (100% versus 87.0% and, respectively, 95.8% versus 83.3%). The addition of CE-CT to 18F-FDG PET/CT did not improve its diagnostic reliability.

CONCLUSION:

18F-FDG PET/CT appears to be the more reliable imaging technique for the evaluation of patients with suspicious recurrent ovarian cancer, and for the selection of those more suitable for secondary cytoreductive surgery.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Platino (Metal) / Tomografía Computarizada por Rayos X / Procedimientos Quirúrgicos de Citorreducción / Tomografía Computarizada por Tomografía de Emisión de Positrones Tipo de estudio: Diagnostic_studies / Observational_studies Límite: Adult / Aged / Female / Humans / Middle aged País/Región como asunto: Europa Idioma: En Revista: Anticancer Res Año: 2020 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Platino (Metal) / Tomografía Computarizada por Rayos X / Procedimientos Quirúrgicos de Citorreducción / Tomografía Computarizada por Tomografía de Emisión de Positrones Tipo de estudio: Diagnostic_studies / Observational_studies Límite: Adult / Aged / Female / Humans / Middle aged País/Región como asunto: Europa Idioma: En Revista: Anticancer Res Año: 2020 Tipo del documento: Article País de afiliación: Italia